The deal is "an important commercial step" for Limaca to push through a wider clinical rollout of Precision-GI, says Trendlines.
The Trendlines Group says that its portfolio company Limaca Medical has inked an exclusive agreement with an unnamed global leader in endoscopy equipment to distribute its Precision-GI biopsy system.
Trendlines and other parties invested US$1.25 million in Limaca Medical back in 2020.
